Compare Relay Therapeutics Inc. Common Stock (RLAY) vs Viasat (VSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Relay Therapeutics Inc. Common Stock vs Viasat — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B), while Viasat trades at $69.2 (market cap $9.76B). The key difference: Viasat is far larger — about 2.5× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Viasat nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Viasat for 10 Days on average.
| RLAY | VSAT | |
|---|---|---|
Market Cap | $3.94B | $9.76B |
Volume | 3,432,928 | 1,739,997 |
Sector | Health | Technology |
52-Week High | $20.75 | $89.81 |
52-Week Low | $6.03 | $30.35 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $3.06B | $14.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →About Viasat
Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →
